Biosafety and Health,
Год журнала:
2023,
Номер
5(2), С. 78 - 88
Опубликована: Янв. 18, 2023
The
coronavirus
disease
2019
(COVID-19)
pandemic
had
a
devastating
impact
on
human
society.
Beginning
with
genome
surveillance
of
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
the
development
omics
technologies
brought
clearer
understanding
complex
SARS-CoV-2
and
COVID-19.
Here,
we
reviewed
how
omics,
including
genomics,
proteomics,
single-cell
multi-omics,
clinical
phenomics,
play
roles
in
answering
biological
questions
about
Large-scale
sequencing
advanced
analysis
methods
facilitate
COVID-19
discovery
from
virus
evolution
severity
risk
prediction
to
potential
treatment
identification.
Omics
would
indicate
precise
globalized
prevention
medicine
for
under
utilization
big
data
capability
phenotypes
refinement.
Furthermore,
decoding
rule
by
deep
learning
models
is
promising
forecast
new
variants
achieve
more
predict
future
pandemics
prevent
them
time.
Signal Transduction and Targeted Therapy,
Год журнала:
2022,
Номер
7(1)
Опубликована: Авг. 1, 2022
Abstract
Apolipoprotein
E
(APOE)
plays
a
pivotal
role
in
lipid
including
cholesterol
metabolism.
The
APOE
ε4
(APOE4)
allele
is
major
genetic
risk
factor
for
Alzheimer’s
and
cardiovascular
diseases.
Although
has
recently
been
associated
with
increased
susceptibility
to
infections
of
several
viruses,
whether
how
its
isoforms
affect
SARS-CoV-2
infection
remains
unclear.
Here,
we
show
that
serum
concentrations
correlate
inversely
levels
cytokine/chemokine
73
COVID-19
patients.
Utilizing
multiple
protein
interaction
assays,
demonstrate
APOE3
APOE4
interact
the
receptor
ACE2;
APOE/ACE2
interactions
require
zinc
metallopeptidase
domain
ACE2,
key
docking
site
Spike
protein.
In
addition,
immuno-imaging
assays
using
confocal,
super-resolution,
transmission
electron
microscopies
reveal
both
reduce
ACE2/Spike-mediated
viral
entry
into
cells.
Interestingly,
while
having
comparable
binding
affinity
inhibits
lesser
extent
compared
APOE3,
which
likely
due
APOE4’s
more
compact
structure
smaller
spatial
obstacle
compete
against
ACE2.
Furthermore,
carriers
clinically
elevated
inflammatory
factors
142
patients
assessed.
Our
study
suggests
regulatory
mechanism
underlying
through
may
explain
part
disease
severity
carriers.
Journal of Clinical Medicine,
Год журнала:
2023,
Номер
12(11), С. 3791 - 3791
Опубликована: Май 31, 2023
Chronic
obstructive
pulmonary
disease
(COPD)
is
significant
cause
of
morbidity
and
mortality
worldwide.
There
mounting
evidence
suggesting
that
COPD
patients
are
at
increased
risk
severe
COVID-19
outcomes;
however,
it
remains
unclear
whether
they
more
susceptible
to
acquiring
SARS-CoV-2
infection.
In
this
comprehensive
review,
we
aim
provide
an
up-to-date
perspective
the
intricate
relationship
between
COVID-19.
We
conducted
a
thorough
review
literature
examine
regarding
susceptibility
infection
severity
their
outcomes.
While
most
studies
have
found
pre-existing
associated
with
worse
outcomes,
some
yielded
conflicting
results.
also
discuss
confounding
factors
such
as
cigarette
smoking,
inhaled
corticosteroids,
socioeconomic
genetic
may
influence
association.
Furthermore,
acute
management,
treatment,
rehabilitation,
recovery
in
how
public
health
measures
impact
care.
conclusion,
while
association
complex
requires
further
investigation,
highlights
need
for
careful
management
during
pandemic
minimize
Immunity Inflammation and Disease,
Год журнала:
2021,
Номер
10(3)
Опубликована: Дек. 22, 2021
Abstract
Background
Abnormal
inflammation
coagulation
biomarker
levels
of
troponin,
C‐reactive
protein
(CRP),
and
D‐dimer
in
serum
have
been
demonstrated
to
be
associated
involved
the
disease
progression
coronavirus
2019
(COVID‐19).
Methods
First:
study
aimed
investigate
correlation
CRP,
d
‐dimer,
white
blood
cell
(WBC)
polymerase
chain
reaction–cycle
threshold
(PCR‐Ct)
within
COVID‐19
survivors
(143
patients;
79
males,
64
females)
deceased
(30
12
18
group.
Also,
assessing
any
differences
between
both
groups
studied
parameters.
Second:
a
parameters'
level
has
conducted
families
(41
23
males
[seven
deaths]
females
[eight
deaths])
that
lost
more
than
one
member
due
severity
disease.
these
family
control
group
(132
69
63
parameters
assessed.
Results
In
first
week
hospitalization,
there
were
significant
D‐dimer,
CRP
troponin
survived
patient
groups.
second
admission,
had
all
parameters;
I,
WBCs.
WBC
positively
correlated
male
(
r
=
0.75,
p
<
0.0001),
patients
0.74,
0.007).
The
admission
was
critical
who
person,
when
with
Conclusion
Troponin,
WBCs
significantly
higher
died
survivors.
High
levels,
considerably
member,
compared
unrelated
control.
International Journal of Medical Sciences,
Год журнала:
2022,
Номер
19(2), С. 402 - 415
Опубликована: Янв. 1, 2022
Hypertension,
diabetes
mellitus,
and
coronary
artery
disease
are
common
comorbidities
dangerous
factors
for
infection
serious
COVID-19.Polymorphisms
in
genes
associated
with
may
help
observe
susceptibility
severity
variation.However,
specific
genetic
the
extent
to
which
they
can
explain
variation
of
unclear.Therefore,
we
evaluated
candidate
COVID-19
hypertension,
disease.In
particular,
performed
searches
against
OMIM,
NCBI,
other
databases,
protein-protein
interaction
network
construction,
GO
KEGG
pathway
enrichment
analyses.Results
showed
that
overlapping
were
TLR4,
NLRP3,
MBL2,
IL6,
IL1RN,
IL1B,
CX3CR1,
CCR5,
AGT,
ACE,
F2.GO
analyses
yielded
302
terms
(q
<
0.05)
29
signaling
pathways
0.05),
respectively,
mainly
including
coronavirus
disease-COVID-19
cytokine-cytokine
receptor
interaction.IL6
AGT
central
PPI,
8
5
connections,
respectively.In
this
study,
identified
11
both
three
contribute
severity.The
key
IL6
involved
regulating
immune
response,
cytokine
activity,
viral
infection.Therefore,
RAAS
inhibitors,
antisense
nucleotides,
vitamin
D,
fenofibrate,
vaccines
non-immune
could
be
potential
strategies
prevent
cure
COVID-19.The
study
provides
a
basis
further
investigation
predictive
value
risk
prognosis
guide
drug
vaccine
development
improve
treatment
efficacy
personalised
treatments,
especially
individuals
comorbidities.
Although
advanced
age,
male
sex,
and
some
comorbidities
impact
the
clinical
course
of
COVID-19,
these
factors
only
partially
explain
inter-individual
variability
in
disease
severity.
Some
studies
have
shown
that
genetic
polymorphisms
contribute
to
COVID-19
severity;
however,
results
are
inconclusive.
Thus,
we
investigated
association
between
ACE1,
ACE2,
DPP9,
IFIH1,
IFNAR2,
IFNL4,
TLR3,
TMPRSS2,
TYK2
COVID-19.
A
total
694
patients
with
were
categorized
as:
(1)
ward
inpatients
(moderate
symptoms)
or
admitted
at
intensive
care
unit
(ICU;
severe
symptoms);
(2)
survivors
non-survivors.
In
females,
rs1990760/IFIH1
T/T
genotype
was
associated
risk
ICU
admission
death.
Moreover,
rs1799752/ACE1
Ins
rs12329760/TMPRSS2
T
alleles
admission.
non-white
patients,
rs2236757/IFNAR2
A/A
admission,
while
Ins/Ins
genotype,
allele
analyzed
interact
worse
outcomes.
conclusion,
this
study
shows
an
rs1799752/ACE1,
rs1990760/IFIH1,
rs2236757/IFNAR2,
rs12329760/TMPRSS2,
rs2304256/TYK2
outcomes,
especially
among
female
patients.
Frontiers in Microbiology,
Год журнала:
2022,
Номер
13
Опубликована: Фев. 10, 2022
The
pandemic
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
led
to
death
of
millions
people
worldwide
and
thousands
more
infected
individuals
developed
sequelae
due
disease
new
2019
(COVID-19).
development
several
studies
has
contributed
knowledge
about
evolution
SARS-CoV2
infection
forms.
Despite
this
information
being
debated
in
scientific
literature,
many
mechanisms
still
need
be
better
understood
order
control
spread
virus
treat
clinical
cases
COVID-19.
In
article,
we
carried
out
an
extensive
literature
review
bring
together,
a
single
biological,
social,
genetic,
diagnostic,
therapeutic,
immunization,
even
socioeconomic
aspects
that
impact
SAR-CoV-2
pandemic.
This
gathered
article
will
enable
broad
consistent
reading
main
related
current
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Фев. 3, 2022
The
novel
SARS-CoV-2
coronavirus
infection
has
become
a
global
health
concern,
causing
the
COVID-19
pandemic.
disease
symptoms
and
outcomes
depend
on
host
immunity,
in
which
human
leukocyte
antigen
(HLA)
molecules
play
distinct
role.
HLA
alleles
have
an
inter-population
variability,
understanding
their
link
to
ethnically
population
may
contribute
personalized
medicine.
present
study
aimed
at
detecting
associations
between
common
susceptibility
severity
Armenians.
In
299
patients
(75
asymptomatic,
102
mild/moderate,
122
severe),
association
classic
HLA-I
II
loci
was
examined.
We
found
that
advanced
age,
male
sex
of
patients,
age
interaction
significantly
contributed
disease.
observed
age-dependent
effect
HLA-B*51:01
carriage
[odds
ratio
(OR)=0.48
(0.28-0.80),
P
Egyptian Journal of Medical Human Genetics,
Год журнала:
2023,
Номер
24(1)
Опубликована: Янв. 22, 2023
COVID-19
is
a
respiratory
disease
caused
by
novel
coronavirus
called
as
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2).
Detected
for
the
first
time
in
December
2019
Wuhan
and
it
has
quickly
spread
all
over
world
couple
of
months
becoming
pandemic.
Symptoms
clinical
outcomes
are
very
different
infected
people.
These
differences
highlight
paramount
need
to
study
understand
human
genetic
variation
that
occurring
viral
infections.
Human
leukocyte
antigen
(HLA)
an
important
component
presentation
pathway,
plays
essential
role
conferring
differential
susceptibility
severity
diseases.
HLA
alleles
have
been
involved
immune
response
diseases
such
SARS-CoV-2.